SG11201908062QA - Insertion mechanism for drug delivery device - Google Patents
Insertion mechanism for drug delivery deviceInfo
- Publication number
- SG11201908062QA SG11201908062QA SG11201908062QA SG11201908062QA SG11201908062QA SG 11201908062Q A SG11201908062Q A SG 11201908062QA SG 11201908062Q A SG11201908062Q A SG 11201908062QA SG 11201908062Q A SG11201908062Q A SG 11201908062QA SG 11201908062Q A SG11201908062Q A SG 11201908062QA
- Authority
- SG
- Singapore
- Prior art keywords
- housing
- hub
- international
- position adjacent
- manifold
- Prior art date
Links
- 238000012377 drug delivery Methods 0.000 title abstract 3
- 238000003780 insertion Methods 0.000 title abstract 3
- 230000037431 insertion Effects 0.000 title abstract 3
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 239000012530 fluid Substances 0.000 abstract 2
- 241000234282 Allium Species 0.000 abstract 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 230000008520 organization Effects 0.000 abstract 1
- 230000037361 pathway Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
- A61M5/14248—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/158—Needles for infusions; Accessories therefor, e.g. for inserting infusion needles, or for holding them on the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31565—Administration mechanisms, i.e. constructional features, modes of administering a dose
- A61M5/31566—Means improving security or handling thereof
- A61M5/31571—Means preventing accidental administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31565—Administration mechanisms, i.e. constructional features, modes of administering a dose
- A61M5/31576—Constructional features or modes of drive mechanisms for piston rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M2005/14208—Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
- A61M5/14248—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type
- A61M2005/14252—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type with needle insertion means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
- A61M5/14248—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type
- A61M2005/14252—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type with needle insertion means
- A61M2005/14256—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type with needle insertion means with means for preventing access to the needle after use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/158—Needles for infusions; Accessories therefor, e.g. for inserting infusion needles, or for holding them on the body
- A61M2005/1585—Needle inserters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/82—Internal energy supply devices
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Replacement Of Web Rolls (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 13 September 2018 (13.09.2018) WIP0 I PCT onion °nolo mu 1°011E1E1E1m oimIE (10) International Publication Number WO 2018/165499 Al (51) International Patent Classification: A61M 5/142 (2006.01) (21) International Application Number: PCT/US2018/021651 (22) International Filing Date: 09 March 2018 (09.03.2018) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 62/469,226 09 March 2017 (09.03.2017) US (71) Applicant: AMGEN INC. [US/US]; One Amgen Center Drive, Thousand Oaks, CA 91320-1799 (US). (72) Inventors: MCCULLOUGH, Adam, B.; 2792 Great Smokey Court, Westlake Village, CA 91362 (US). COIN- ER, Erich; 14684 Carlson St., Poway, CA 92064 (US). PAYNE, Alan, D.; 1470 La Honda Dr., Escondido, CA 92027 (US). (74) Agent: FURMANEK, Michael, P.; Marshall, Gerstien & Borun LLP, 233 S. Wacker Drive, 6300 Willis Tower, Chicago, IL 60606-6357 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Published: — with international search report (Art. 21(3)) 1-1 ON (54) Title: INSERTION MECHANISM FOR DRUG DELIVERY DEVICE 01 i v (57) : An insertion mechanism for a drug delivery device including a trocar, a housing, and a manifold in fluid communication In with a fluid pathway connector and movable relative to the housing between a first manifold position adjacent to a proximal end of the housing and a second manifold position adjacent to a distal end of the housing. A hub carrying the trocar or hollow delivery needle 1-1 is removably connected to the manifold, the hub being movable relative to the housing between a first hub position adjacent to the proximal end of the housing and a second hub position adjacent to the distal end of the housing. A power source is configured to 1-1 © generate rotational motion. A motion conversion mechanism operatively connects the power source and the hub, and is configured to N convert the rotational motion into linear motion of the hub.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762469226P | 2017-03-09 | 2017-03-09 | |
PCT/US2018/021651 WO2018165499A1 (en) | 2017-03-09 | 2018-03-09 | Insertion mechanism for drug delivery device |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201908062QA true SG11201908062QA (en) | 2019-09-27 |
Family
ID=61768511
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201908062QA SG11201908062QA (en) | 2017-03-09 | 2018-03-09 | Insertion mechanism for drug delivery device |
Country Status (10)
Country | Link |
---|---|
US (2) | US11986624B2 (en) |
EP (1) | EP3592404A1 (en) |
JP (2) | JP2020509837A (en) |
KR (2) | KR20240005194A (en) |
AU (2) | AU2018230486B2 (en) |
CA (1) | CA3052310A1 (en) |
IL (2) | IL268386B2 (en) |
MX (1) | MX2019010671A (en) |
SG (1) | SG11201908062QA (en) |
WO (1) | WO2018165499A1 (en) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1762259B1 (en) | 2005-09-12 | 2010-09-08 | Unomedical A/S | Inserter for an infusion set with a first and second spring units |
WO2012123274A1 (en) | 2011-03-14 | 2012-09-20 | Unomedical A/S | Inserter system with transport protection |
PL3377146T3 (en) | 2015-11-20 | 2021-10-11 | Amf Medical Sa | Micropump and method of manufacturing a micropump |
US11529458B2 (en) | 2017-12-08 | 2022-12-20 | Amf Medical Sa | Drug delivery device |
US11554213B2 (en) | 2018-09-22 | 2023-01-17 | Shl Medical Ag | Injector needle insertion retraction assembly |
US20210402084A1 (en) * | 2018-11-08 | 2021-12-30 | Capillary Biomedical, Inc. | Linear insertion device with rotational drive |
IT201800020467A1 (en) * | 2018-12-20 | 2020-06-20 | Medirio Sa | DEVICE AND SYSTEM FOR ADMINISTRATION OF A MEDICAL FLUID AND RELATIVE METHOD OF ADMINISTRATION |
FR3093437B1 (en) * | 2019-03-07 | 2024-05-24 | Nemera La Verpilliere | Device for inserting a needle for dispensing a product in a site |
CN113950341B (en) | 2019-05-20 | 2024-03-19 | 优诺医疗有限公司 | Rotatable infusion device and method therefor |
US11951281B2 (en) | 2020-11-11 | 2024-04-09 | Medtronic Minimed, Inc. | Fluid conduit insertion devices |
US11806505B2 (en) | 2020-12-02 | 2023-11-07 | Medtronic Minimed, Inc. | Single-site insertion of multiple medical devices |
US11738140B2 (en) | 2021-01-15 | 2023-08-29 | Medtronic Minimed, Inc. | Insertion device with linkage assembly |
US11944786B2 (en) | 2021-01-18 | 2024-04-02 | Medtronic Minimed, Inc. | Infusion device |
US11872369B1 (en) | 2021-02-18 | 2024-01-16 | Fresenius Kabi Deutschland Gmbh | Wearable medicament delivery device with leakage and skin contact sensing and method of use thereof |
US11464902B1 (en) | 2021-02-18 | 2022-10-11 | Fresenius Kabi Deutschland Gmbh | Wearable medicament delivery device with compressible reservoir and method of use thereof |
US11311666B1 (en) | 2021-02-18 | 2022-04-26 | Fresenius Kabi Deutschland Gmbh | Modular wearable medicament delivery device and method of use thereof |
US11497847B1 (en) | 2021-02-19 | 2022-11-15 | Fresenius Kabi Deutschland Gmbh | Wearable injector with adhesive substrate |
US11426523B1 (en) | 2021-02-19 | 2022-08-30 | Fresenius Kabi Deutschland Gmbh | Drug delivery assembly including a removable cartridge |
US11413394B1 (en) | 2021-02-19 | 2022-08-16 | Fresenius Kabi Deutschland Gmbh | Display for wearable drug delivery device |
US11633537B1 (en) | 2021-02-19 | 2023-04-25 | Fresenius Kabi Deutschland Gmbh | Drug delivery assembly including a pre-filled cartridge |
US11406755B1 (en) | 2021-02-19 | 2022-08-09 | Fresenius Kabi Deutschland Gmbh | Sensing fluid flow irregularities in an on-body injector |
US11344682B1 (en) | 2021-02-19 | 2022-05-31 | Fresenius Kabi Deutschland Gmbh | Drug supply cartridge with visual use indicator and delivery devices that use the same |
US11607505B1 (en) | 2021-02-19 | 2023-03-21 | Fresenius Kabi Deutschland Gmbh | Wearable injector with sterility sensors |
US11419976B1 (en) | 2021-04-30 | 2022-08-23 | Fresenius Kabi Deutschland Gmbh | Wearable drug delivery device with pressurized fluid dispensing |
US11529459B1 (en) | 2021-04-30 | 2022-12-20 | Fresenius Kabi Deutschland Gmbh | Wearable injector with adhesive module |
US11351300B1 (en) | 2021-04-30 | 2022-06-07 | Fresenius Kabl Deutschland GmbH | Drug dispensing system with replaceable drug supply cartridges |
US11504470B1 (en) | 2021-04-30 | 2022-11-22 | Fresenius Kabi Deutschland Gmbh | Deformable drug reservoir for wearable drug delivery device |
US11717608B1 (en) | 2021-05-03 | 2023-08-08 | Fresenius Kabi Deutschland Gmbh | Drug delivery assembly including an adhesive pad |
US11484646B1 (en) | 2021-05-04 | 2022-11-01 | Fresenius Kabi Deutschland Gmbh | Sealing systems for a reservoir of an on-body injector |
US11679199B2 (en) | 2021-06-01 | 2023-06-20 | Amf Medical Sa | Systems and methods for delivering microdoses of medication |
US11529464B1 (en) | 2021-06-01 | 2022-12-20 | Amf Medical Sa | Systems and methods for monitoring delivery of microdoses of medication |
US11857757B2 (en) | 2021-06-01 | 2024-01-02 | Tandem Diabetes Care Switzerland Sàrl | Systems and methods for delivering microdoses of medication |
WO2023232496A1 (en) * | 2022-06-03 | 2023-12-07 | Shl Medical Ag | On-body injection device |
Family Cites Families (160)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4703008A (en) | 1983-12-13 | 1987-10-27 | Kiren-Amgen, Inc. | DNA sequences encoding erythropoietin |
NZ210501A (en) | 1983-12-13 | 1991-08-27 | Kirin Amgen Inc | Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence |
KR850004274A (en) | 1983-12-13 | 1985-07-11 | 원본미기재 | Method for preparing erythropoietin |
US5856298A (en) | 1989-10-13 | 1999-01-05 | Amgen Inc. | Erythropoietin isoforms |
WO1991005867A1 (en) | 1989-10-13 | 1991-05-02 | Amgen Inc. | Erythropoietin isoforms |
US7217689B1 (en) | 1989-10-13 | 2007-05-15 | Amgen Inc. | Glycosylation analogs of erythropoietin |
IL192290A0 (en) | 1993-08-17 | 2008-12-29 | Kirin Amgen Inc | Erythropoietin analogs |
US6562596B1 (en) | 1993-10-06 | 2003-05-13 | Amgen Inc. | Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods |
US5773569A (en) | 1993-11-19 | 1998-06-30 | Affymax Technologies N.V. | Compounds and peptides that bind to the erythropoietin receptor |
US5830851A (en) | 1993-11-19 | 1998-11-03 | Affymax Technologies N.V. | Methods of administering peptides that bind to the erythropoietin receptor |
US5885574A (en) | 1994-07-26 | 1999-03-23 | Amgen Inc. | Antibodies which activate an erythropoietin receptor |
IL114909A (en) | 1994-08-12 | 1999-10-28 | Immunomedics Inc | Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells |
US5686292A (en) | 1995-06-02 | 1997-11-11 | Genentech, Inc. | Hepatocyte growth factor receptor antagonist antibodies and uses thereof |
US5767078A (en) | 1995-06-07 | 1998-06-16 | Johnson; Dana L. | Agonist peptide dimers |
US6753165B1 (en) | 1999-01-14 | 2004-06-22 | Bolder Biotechnology, Inc. | Methods for making proteins containing free cysteine residues |
WO1999003887A1 (en) | 1997-07-14 | 1999-01-28 | Bolder Biotechnology, Inc. | Derivatives of growth hormone and related proteins |
KR100641969B1 (en) | 1997-07-23 | 2006-11-06 | 로셰 디아그노스틱스 게엠베하 | Production of erythropoietin by endogenous gene activation |
US6030086A (en) | 1998-03-02 | 2000-02-29 | Becton, Dickinson And Company | Flash tube reflector with arc guide |
US6310078B1 (en) | 1998-04-20 | 2001-10-30 | Ortho-Mcneil Pharmaceutical, Inc. | Substituted amino acids as erythropoietin mimetics |
US20050181482A1 (en) | 2004-02-12 | 2005-08-18 | Meade Harry M. | Method for the production of an erythropoietin analog-human IgG fusion proteins in transgenic mammal milk |
EP1088084B1 (en) | 1998-06-15 | 2006-09-13 | GTC Biotherapeutics, Inc. | Erythropoietin analog-human serum albumin fusion protein |
ATE355303T1 (en) | 1998-10-23 | 2006-03-15 | Amgen Inc | METHODS AND COMPOSITIONS FOR PREVENTION AND TREATMENT OF ANEMIA |
SI2319928T1 (en) | 1998-10-23 | 2013-08-30 | Kirin-Amgen, Inc. | Dimeric thrombopoietin peptide mimetics binding to MP1 receptor and having thrombopoietic activity |
NZ552959A (en) | 1998-11-27 | 2008-06-30 | Darwin Discovery Ltd | Compositions and methods for increasing bone mineralization |
EP1006184A1 (en) | 1998-12-03 | 2000-06-07 | F. Hoffmann-La Roche Ag | IGF-1 receptor interacting proteins (IIPs) genes coding therefor and uses thereof |
WO2000061637A1 (en) | 1999-04-14 | 2000-10-19 | Smithkline Beecham Corporation | Erythropoietin receptor antibodies |
US7297680B2 (en) | 1999-04-15 | 2007-11-20 | Crucell Holland B.V. | Compositions of erythropoietin isoforms comprising Lewis-X structures and high sialic acid content |
CZ299516B6 (en) | 1999-07-02 | 2008-08-20 | F. Hoffmann-La Roche Ag | Erythropoietin glycoprotein conjugate, process for its preparation and use and pharmaceutical composition containing thereof |
AU1099601A (en) | 1999-10-22 | 2001-05-08 | Millennium Pharmaceuticals, Inc. | Nucleic acid molecules derived from rat brain and programmed cell death models |
JP2003514552A (en) | 1999-11-12 | 2003-04-22 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | Erythropoietin morphology with improved properties |
US20050202538A1 (en) | 1999-11-12 | 2005-09-15 | Merck Patent Gmbh | Fc-erythropoietin fusion protein with improved pharmacokinetics |
KR100768408B1 (en) | 2000-01-21 | 2007-10-18 | 바이오벡스 리미티드 | Herpes Virus Strains |
AUPQ599700A0 (en) | 2000-03-03 | 2000-03-23 | Super Internet Site System Pty Ltd | On-line geographical directory |
US6586398B1 (en) | 2000-04-07 | 2003-07-01 | Amgen, Inc. | Chemically modified novel erythropoietin stimulating protein compositions and methods |
DK1274728T3 (en) | 2000-04-21 | 2008-09-01 | Amgen Inc | Methods and compositions for the prevention and treatment of anemia |
US6756480B2 (en) | 2000-04-27 | 2004-06-29 | Amgen Inc. | Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
US7078376B1 (en) | 2000-08-11 | 2006-07-18 | Baxter Healthcare S.A. | Therapeutic methods for treating subjects with a recombinant erythropoietin having high activity and reduced side effects |
EP1315513B1 (en) | 2000-09-08 | 2011-03-09 | Amylin Pharmaceuticals, Inc. | "pseudo"-native chemical ligation |
US7271689B1 (en) | 2000-11-22 | 2007-09-18 | Fonar Corporation | Magnet structure |
WO2002049673A2 (en) | 2000-12-20 | 2002-06-27 | F. Hoffmann-La Roche Ag | Conjugates of erythropoietin (pep) with polyethylene glycol (peg) |
WO2002053596A2 (en) | 2001-01-05 | 2002-07-11 | Pfizer Inc. | Antibodies to insulin-like growth factor i receptor |
IL158261A0 (en) | 2001-04-04 | 2004-05-12 | Genodyssee | New polynucleotides and polypeptides of the erythropoietin gene |
EP1921088B1 (en) | 2001-05-11 | 2014-10-08 | Amgen Inc. | Peptides and related molecules that bind to tall-1 |
CN1547486A (en) | 2001-06-26 | 2004-11-17 | Antibodies to OPGL | |
US6900292B2 (en) | 2001-08-17 | 2005-05-31 | Lee-Hwei K. Sun | Fc fusion proteins of human erythropoietin with increased biological activities |
US7153507B2 (en) | 2001-08-23 | 2006-12-26 | Genmab A/S | Human antibodies specific for interleukin 15 (IL-15) |
US7247304B2 (en) | 2001-08-23 | 2007-07-24 | Genmab A/S | Methods of treating using anti-IL-15 antibodies |
US6930086B2 (en) | 2001-09-25 | 2005-08-16 | Hoffmann-La Roche Inc. | Diglycosylated erythropoietin |
US7214660B2 (en) | 2001-10-10 | 2007-05-08 | Neose Technologies, Inc. | Erythropoietin: remodeling and glycoconjugation of erythropoietin |
US7521053B2 (en) | 2001-10-11 | 2009-04-21 | Amgen Inc. | Angiopoietin-2 specific binding agents |
US7138370B2 (en) | 2001-10-11 | 2006-11-21 | Amgen Inc. | Specific binding agents of human angiopoietin-2 |
AU2002351746A1 (en) | 2001-12-21 | 2003-07-15 | Maxygen Aps | Erythropoietin conjugates |
US7241444B2 (en) | 2002-01-18 | 2007-07-10 | Pierre Fabre Medicament | Anti-IGF-IR antibodies and uses thereof |
JP4606739B2 (en) | 2002-01-18 | 2011-01-05 | ピエール、ファーブル、メディカマン | Novel anti-IGF-IR antibodies and uses thereof |
EP1470232A1 (en) | 2002-01-31 | 2004-10-27 | Oxford Biomedica (UK) Limited | Physiologically regulated erythropoietin-expressing vector for the treatment of anaemia |
GB0202252D0 (en) | 2002-01-31 | 2002-03-20 | Oxford Biomedica Ltd | Anemia |
ATE363541T1 (en) | 2002-03-26 | 2007-06-15 | Lek Tovarna Farmacevtskih | METHOD FOR PRODUCING A DESIRED PROFILE OF ERYTHROPOIETIN GLYCO ISOFORMS |
EP1572079A4 (en) | 2002-03-29 | 2006-09-06 | Centocor Inc | Mammalian cdr mimetibodies, compositions, methods and uses |
WO2003083118A1 (en) | 2002-03-29 | 2003-10-09 | Kumiai Chemical Industry Co., Ltd. | Genes encoding acetolactate synthase |
US20040009902A1 (en) | 2002-05-13 | 2004-01-15 | Irving Boime | CTP extended erythropoietin |
JP4563171B2 (en) | 2002-05-24 | 2010-10-13 | シェーリング コーポレイション | Neutralizing human anti-IGFR antibody |
US8034904B2 (en) | 2002-06-14 | 2011-10-11 | Immunogen Inc. | Anti-IGF-I receptor antibody |
US7538195B2 (en) | 2002-06-14 | 2009-05-26 | Immunogen Inc. | Anti-IGF-I receptor antibody |
AU2003280130B2 (en) | 2002-06-28 | 2009-06-11 | Centocor, Inc. | Mammalian CH1 deleted mimetibodies, compositions, methods and uses |
WO2004002424A2 (en) | 2002-06-28 | 2004-01-08 | Centocor, Inc. | Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
WO2004009627A1 (en) | 2002-07-19 | 2004-01-29 | Cangene Corporation | Pegylated erythropoietic compounds |
AU2003254950A1 (en) | 2002-08-26 | 2004-03-11 | Kirin Beer Kabushiki Kaisha | Peptides and drugs containing the same |
EA018072B1 (en) | 2002-09-06 | 2013-05-30 | Амджен Инк. | Antibody to interleukine-1 receptor type 1 (il-1r1) and use thereof |
WO2005025606A1 (en) | 2003-09-09 | 2005-03-24 | Warren Pharmaceuticals, Inc. | Long acting erythropoietins that maintain tissue protective activity of endogenous erythropoietin |
CA2495242A1 (en) | 2002-09-11 | 2004-03-25 | Fresenius Kabi Deutschland Gmbh | Hasylated polypeptides, especially hasylated erythropoietin |
US6919426B2 (en) | 2002-09-19 | 2005-07-19 | Amgen Inc. | Peptides and related molecules that modulate nerve growth factor activity |
TWI320716B (en) | 2002-10-14 | 2010-02-21 | Abbott Lab | Erythropoietin receptor binding antibodies |
US20040071694A1 (en) | 2002-10-14 | 2004-04-15 | Devries Peter J. | Erythropoietin receptor binding antibodies |
US7396913B2 (en) | 2002-10-14 | 2008-07-08 | Abbott Laboratories | Erythropoietin receptor binding antibodies |
AU2003285874A1 (en) | 2002-10-16 | 2004-05-04 | Amgen Inc. | HUMAN ANTI-IFN-Gamma NEUTRALIZING ANTIBODIES AS SELECTIVE IFN-Gamma PATHWAY INHIBITORS |
US20040091961A1 (en) | 2002-11-08 | 2004-05-13 | Evans Glen A. | Enhanced variants of erythropoietin and methods of use |
NZ541253A (en) | 2002-12-20 | 2010-03-26 | Amgen Inc | Peptide binding agents which inhibit myostatin |
EP1603948A1 (en) | 2003-03-14 | 2005-12-14 | Pharmacia Corporation | Antibodies to igf-i receptor for the treatment of cancers |
ES2383014T3 (en) | 2003-04-02 | 2012-06-15 | F. Hoffmann-La Roche Ag | Antibodies against insulin-like growth factor I and their uses |
US7220410B2 (en) | 2003-04-18 | 2007-05-22 | Galaxy Biotech, Llc | Monoclonal antibodies to hepatocyte growth factor |
WO2005016970A2 (en) | 2003-05-01 | 2005-02-24 | Imclone Systems Incorporated | Fully human antibodies directed against the human insulin-like growth factor-1 receptor |
TWI353991B (en) | 2003-05-06 | 2011-12-11 | Syntonix Pharmaceuticals Inc | Immunoglobulin chimeric monomer-dimer hybrids |
MXPA05012315A (en) | 2003-05-12 | 2006-04-18 | Affymax Inc | Novel poly(ethylene glycol) modified compounds and uses thereof. |
SI1625156T1 (en) | 2003-05-12 | 2013-02-28 | Affymax, Inc. | Peptides that bind to the erythropoietin receptor |
AU2004238870B8 (en) | 2003-05-12 | 2010-04-15 | Affymax, Inc. | Novel peptides that bind to the erythropoietin receptor |
US7074755B2 (en) | 2003-05-17 | 2006-07-11 | Centocor, Inc. | Erythropoietin conjugate compounds with extended half-lives |
CA2527665A1 (en) | 2003-05-30 | 2004-12-16 | Centocor, Inc. | Formation of novel erythropoietin conjugates using transglutaminase |
WO2005001136A1 (en) | 2003-06-04 | 2005-01-06 | Irm Llc | Methods and compositions for modulating erythropoietin expression |
AR046071A1 (en) | 2003-07-10 | 2005-11-23 | Hoffmann La Roche | ANTIBODIES AGAINST RECEIVER I OF THE INSULINAL TYPE GROWTH FACTOR AND THE USES OF THE SAME |
SI1648509T1 (en) | 2003-07-15 | 2012-12-31 | Amgen Inc. | Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors |
PL1648998T3 (en) | 2003-07-18 | 2015-03-31 | Amgen Inc | Specific binding agents to hepatocyte growth factor |
US20050019914A1 (en) | 2003-07-24 | 2005-01-27 | Aventis Pharma Deutschland Gmbh | Perfusion process for producing erythropoietin |
GB0317511D0 (en) | 2003-07-25 | 2003-08-27 | Biovex Ltd | Viral vectors |
CA2535138C (en) * | 2003-08-12 | 2013-01-08 | Becton, Dickinson And Company | Patch-like infusion device |
EP1663278A4 (en) | 2003-08-28 | 2009-07-29 | Biorexis Pharmaceutical Corp | Epo mimetic peptides and fusion proteins |
WO2005081687A2 (en) | 2003-09-30 | 2005-09-09 | Centocor, Inc. | Human hinge core mimetibodies, compositions, methods and uses |
UA89481C2 (en) | 2003-09-30 | 2010-02-10 | Центокор, Инк. | Human epo mimetic hinge core mimetibodies, compositions, methods and uses |
ATE548388T1 (en) | 2003-11-07 | 2012-03-15 | Immunex Corp | ANTIBODIES BINDING TO THE INTERLEUKIN-4 RECEPTOR |
TW200526684A (en) | 2003-11-21 | 2005-08-16 | Schering Corp | Anti-IGFR1 antibody therapeutic combinations |
MXPA06005732A (en) | 2003-11-24 | 2006-08-17 | Neose Technologies Inc | Glycopegylated erythropoietin. |
US8633157B2 (en) | 2003-11-24 | 2014-01-21 | Novo Nordisk A/S | Glycopegylated erythropoietin |
WO2005058967A2 (en) | 2003-12-16 | 2005-06-30 | Pierre Fabre Medicament | Novel anti-insulin/igf-i hybrid receptor or anti-insulin/igf-i hybrid receptor and igf-ir antibodies and uses thereof |
EP1548031A1 (en) | 2003-12-22 | 2005-06-29 | Dubai Genetics FZ-LLC | Nature-identical erythropoietin |
WO2005065239A2 (en) | 2003-12-31 | 2005-07-21 | Centocor, Inc. | Novel recombinant proteins with n-terminal free thiol |
CA2551916C (en) | 2003-12-31 | 2014-04-29 | Merck Patent Gesellschaft Mit Beschraenkter Haftung | Fc-erythropoietin fusion protein with improved pharmacokinetics |
US7423139B2 (en) | 2004-01-20 | 2008-09-09 | Insight Biopharmaceuticals Ltd. | High level expression of recombinant human erythropoietin having a modified 5′-UTR |
WO2005070451A1 (en) | 2004-01-22 | 2005-08-04 | Zafena Aktiebolag | Pharmaceutical composition comprising non-glycosylated erythropoietin |
WO2005084711A1 (en) | 2004-03-02 | 2005-09-15 | Chengdu Institute Of Biological Products | A pegylated recombinant erythropoietin that has in vivo activity |
EP1758608A2 (en) | 2004-03-11 | 2007-03-07 | Fresenius Kabi Deutschland GmbH | Conjugates of hydroxyethyl starch and erythropoietin |
CA2560889A1 (en) | 2004-03-23 | 2005-10-13 | Sanjay D. Khare | Monoclonal antibodies specific for human ox40l (cd 134l) |
US20050227289A1 (en) | 2004-04-09 | 2005-10-13 | Reilly Edward B | Antibodies to erythropoietin receptor and uses thereof |
EP1737888A2 (en) | 2004-04-23 | 2007-01-03 | Cambridge Antibody Technology LTD | Erythropoietin protein variants |
DE602005014117D1 (en) | 2004-07-07 | 2009-06-04 | Lundbeck As Valby H | NEW CARBAMYLATED EPO AND METHOD FOR THE PRODUCTION THEREOF |
FR2873699B1 (en) | 2004-07-29 | 2009-08-21 | Pierre Fabre Medicament Sa | NOVEL ANTI-IGF ANTIBODIES IR RT USES THEREOF |
US20060073563A1 (en) | 2004-09-02 | 2006-04-06 | Xencor, Inc. | Erythropoietin derivatives with altered immunogenicity |
WO2006050959A2 (en) | 2004-11-10 | 2006-05-18 | Aplagen Gmbh | Molecules which promote hematopoiesis |
MY146381A (en) | 2004-12-22 | 2012-08-15 | Amgen Inc | Compositions and methods relating relating to anti-igf-1 receptor antibodies |
US7906625B2 (en) | 2005-01-24 | 2011-03-15 | Amgen Inc. | Humanized anti-amyloid antibody |
US7592429B2 (en) | 2005-05-03 | 2009-09-22 | Ucb Sa | Sclerostin-binding antibody |
BRPI0611984A2 (en) | 2005-06-17 | 2009-07-07 | Imclone Systems Inc | use of igf-ir antibodies to manufacture a drug to treat a bone tumor |
WO2007000328A1 (en) | 2005-06-27 | 2007-01-04 | Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa | Antibodies that bind to an epitope on insulin-like growth factor 1 receptor and uses thereof |
NO345593B1 (en) | 2005-07-18 | 2021-05-03 | Amgen Inc | Human anti-B7RP1 neutralizing antibodies |
FR2888850B1 (en) | 2005-07-22 | 2013-01-11 | Pf Medicament | NOVEL ANTI-IGF-IR ANTIBODIES AND THEIR APPLICATIONS |
PE20071101A1 (en) | 2005-08-31 | 2007-12-21 | Amgen Inc | POLYPEPTIDES AND ANTIBODIES |
GB0603683D0 (en) | 2006-02-23 | 2006-04-05 | Novartis Ag | Organic compounds |
TWI395754B (en) | 2006-04-24 | 2013-05-11 | Amgen Inc | Humanized c-kit antibody |
WO2007136752A2 (en) | 2006-05-19 | 2007-11-29 | Glycofi, Inc. | Erythropoietin compositions |
US7736338B2 (en) * | 2006-08-23 | 2010-06-15 | Medtronic Minimed, Inc. | Infusion medium delivery system, device and method with needle inserter and needle inserter device and method |
CL2007002567A1 (en) | 2006-09-08 | 2008-02-01 | Amgen Inc | ISOLATED PROTEINS FROM LINK TO ACTIVINE TO HUMAN. |
CN101636179B (en) | 2006-11-07 | 2012-10-10 | 默沙东公司 | Antagonists of pcsk9 |
US20100040610A1 (en) | 2006-11-07 | 2010-02-18 | Ayesha Sitlani | Antagonists of pcsk9 |
EP2083860A4 (en) | 2006-11-07 | 2010-05-26 | Merck Sharp & Dohme | Antagonists of pcsk9 |
WO2008057457A2 (en) | 2006-11-07 | 2008-05-15 | Merck & Co., Inc. | Antagonists of pcsk9 |
US8232372B2 (en) | 2006-12-14 | 2012-07-31 | Schering Corp. | Engineered anti-TSLP antibody |
US20100233177A1 (en) | 2007-04-13 | 2010-09-16 | David Langdon Yowe | Molecules and methods for modulating proprotein convertase subtilisin/kexin type 9 (pcsk9) |
CN102027012A (en) | 2007-06-20 | 2011-04-20 | Irm责任有限公司 | Methods and compositions for treating allergic diseases |
US7982016B2 (en) | 2007-09-10 | 2011-07-19 | Amgen Inc. | Antigen binding proteins capable of binding thymic stromal lymphopoietin |
CA2703712A1 (en) | 2007-10-26 | 2009-04-30 | Joseph A. Hedrick | Anti-pcsk9 and methods for treating lipid and cholesterol disorders |
AR070315A1 (en) | 2008-02-07 | 2010-03-31 | Merck & Co Inc | ANTIBODIES 1B20 ANTAGONISTS OF PCSK9 |
AR070316A1 (en) | 2008-02-07 | 2010-03-31 | Merck & Co Inc | PCSK9 ANTAGONISTS (SUBTILISINE-KEXINA TYPE 9 PROPROTEIN) |
TWI516501B (en) | 2008-09-12 | 2016-01-11 | 禮納特神經系統科學公司 | Pcsk9 antagonists |
JO3672B1 (en) | 2008-12-15 | 2020-08-27 | Regeneron Pharma | High Affinity Human Antibodies to PCSK9 |
JO3382B1 (en) | 2008-12-23 | 2019-03-13 | Amgen Inc | Human cgrp receptor binding antibodies |
WO2011037791A1 (en) | 2009-09-25 | 2011-03-31 | Merck Sharp & Dohme Corp. | Antagonists of pcsk9 |
CN102639150A (en) | 2009-10-30 | 2012-08-15 | 默沙东公司 | AX213 and AX132 PCSK9 antagonists and variants |
AU2010313381A1 (en) | 2009-10-30 | 2012-04-12 | Merck Sharp & Dohme Corp. | AX1 and AX189 PCSK9 antagonists and variants |
AR079336A1 (en) | 2009-12-11 | 2012-01-18 | Irm Llc | ANTAGONISTS OF THE PRO-PROTEIN CONVERTASE-SUBTILISINE / TYPE 9 QUEXINE (PCSK9) |
SA111320266B1 (en) | 2010-03-11 | 2015-06-21 | رينات نيوروساينس كوربوريشن | Antibodies with pH Dependent Antigen Binding |
WO2012054438A1 (en) | 2010-10-22 | 2012-04-26 | Schering Corporation | Anti-pcsk9 |
US20120195910A1 (en) | 2010-12-22 | 2012-08-02 | Genentech, Inc. | Anti-pcsk9 antibodies and methods of use |
KR20200133826A (en) | 2011-01-28 | 2020-11-30 | 사노피 바이오테크놀로지, 소시에떼 빠르 악씨옹 셍쁠리피에 | Human antibodies to pcsk9 for use in methods of treating particular groups of subjects |
EP2673302A1 (en) | 2011-02-11 | 2013-12-18 | Irm Llc | Pcsk9 antagonists |
JOP20200043A1 (en) | 2011-05-10 | 2017-06-16 | Amgen Inc | Methods of treating or preventing cholesterol related disorders |
US9511189B2 (en) | 2011-09-02 | 2016-12-06 | Unitract Syringe Pty Ltd | Insertion mechanism for a drug delivery pump |
EP2935311B1 (en) | 2012-12-20 | 2021-03-31 | Amgen Inc. | Apj receptor agonists and uses thereof |
US20140274874A1 (en) | 2013-03-14 | 2014-09-18 | Amgen Inc. | Variants of tissue inhibitor of metalloproteinase type three (timp-3), compositions and methods |
SG10201804469RA (en) | 2013-03-14 | 2018-06-28 | Amgen Inc | Variants of tissue inhibitor of metalloproteinase type three (timp-3), compositions and methods |
US10080839B2 (en) | 2013-03-14 | 2018-09-25 | Becton, Dickinson And Company | Angled inserter for drug infusion |
DK3041529T3 (en) * | 2013-09-05 | 2019-03-11 | Sanofi Aventis Deutschland | DEVICE FOR CANNEL INSTALLATION AND WITHDRAWAL WITH MANUALLY LOCKABLE, SPRING LOADED DRIVE MECHANISM |
US10195342B2 (en) * | 2014-04-24 | 2019-02-05 | Becton, Dickinson And Company | Cannula deployment mechanism |
-
2018
- 2018-03-09 IL IL268386A patent/IL268386B2/en unknown
- 2018-03-09 AU AU2018230486A patent/AU2018230486B2/en active Active
- 2018-03-09 JP JP2019548661A patent/JP2020509837A/en active Pending
- 2018-03-09 EP EP18713517.3A patent/EP3592404A1/en active Pending
- 2018-03-09 US US16/489,833 patent/US11986624B2/en active Active
- 2018-03-09 SG SG11201908062QA patent/SG11201908062QA/en unknown
- 2018-03-09 WO PCT/US2018/021651 patent/WO2018165499A1/en unknown
- 2018-03-09 KR KR1020237044629A patent/KR20240005194A/en active Search and Examination
- 2018-03-09 IL IL303449A patent/IL303449B1/en unknown
- 2018-03-09 MX MX2019010671A patent/MX2019010671A/en unknown
- 2018-03-09 CA CA3052310A patent/CA3052310A1/en active Pending
- 2018-03-09 KR KR1020197029229A patent/KR102619150B1/en active IP Right Grant
-
2020
- 2020-11-16 US US17/099,137 patent/US11464900B2/en active Active
-
2023
- 2023-03-14 JP JP2023039347A patent/JP7482279B2/en active Active
- 2023-08-03 AU AU2023210635A patent/AU2023210635A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
JP7482279B2 (en) | 2024-05-13 |
IL303449B1 (en) | 2024-04-01 |
IL268386B2 (en) | 2023-11-01 |
WO2018165499A1 (en) | 2018-09-13 |
US11986624B2 (en) | 2024-05-21 |
KR20240005194A (en) | 2024-01-11 |
MX2019010671A (en) | 2019-10-21 |
EP3592404A1 (en) | 2020-01-15 |
AU2018230486A1 (en) | 2019-08-22 |
IL268386B1 (en) | 2023-07-01 |
KR20190123319A (en) | 2019-10-31 |
JP2023072036A (en) | 2023-05-23 |
AU2023210635A1 (en) | 2023-08-24 |
CA3052310A1 (en) | 2018-09-13 |
AU2018230486B2 (en) | 2023-05-11 |
US11464900B2 (en) | 2022-10-11 |
US20210077713A1 (en) | 2021-03-18 |
IL268386A (en) | 2019-09-26 |
US20200023122A1 (en) | 2020-01-23 |
KR102619150B1 (en) | 2023-12-27 |
IL303449A (en) | 2023-08-01 |
JP2020509837A (en) | 2020-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201908062QA (en) | Insertion mechanism for drug delivery device | |
SG11201807252QA (en) | Anti-lag-3 antibodies | |
SG11201809857TA (en) | Anti-CTLA-4 Antibodies | |
SG11201806485RA (en) | Pyrrolobenzodiazepine conjugates | |
SG11201805324SA (en) | Robotic devices and systems for performing single incision procedures and natural orifice translumenal endoscopic surgical procedures, and methods of configuring robotic devices and systems | |
SG11201810391RA (en) | Medical devices, systems and methods utilizing permanent magnet and magnetizable feature | |
SG11201804836RA (en) | Treatment of fibrosis | |
SG11201804915RA (en) | Methods for treating huntington's disease | |
SG11201903270RA (en) | Method and system for selective access of stored or transmitted bioinformatics data | |
SG11201803686UA (en) | Prodrugs of a jak inhibitor compound for treatment of gastrointestinal inflammatory disease | |
SG11201803767YA (en) | A microneedle and a chip | |
SG11201407747QA (en) | A method and apparatus for facilitating the management of health and security | |
SG11201809908TA (en) | Stabilized glycopeptide antibiotic formulations | |
SG11201407486PA (en) | Compositions and methods for modulating utrn expression | |
SG11201810429UA (en) | Anti-cd19 antibody formulations | |
SG11201900554YA (en) | Spiro-lactam nmda modulators and methods of using same | |
SG11201809809YA (en) | Electro-magnetic needle catheter insertion system | |
SG11201809341PA (en) | Mobile robot | |
SG11201901094YA (en) | A collapsible conduit, patient interface and headgear connector | |
SG11201908042TA (en) | Smartcard | |
SG11201805325VA (en) | Robotic devices and systems for performing single incision procedures and natural orifice translumenal endoscopic surgical procedures, and methods of configuring robotic devices and systems | |
SG11201901351UA (en) | A patient interface, system and method | |
SG11201900412VA (en) | A gripper device for gripping a pipe | |
SG11201901374WA (en) | Antibiotic compounds | |
SG11201810637VA (en) | Endoscopy system components |